Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Lung Cancer
Filter by Topic
Lung Adenocarcinoma
2021 Midyear Review: Non–Small-Cell Lung Cancer
Lung Cancer
Read More ›
ctDNA May Be a Biomarker for Postsurgery MRD Positivity and Relapse in Patients with NSCLC
Web Exclusives
,
Lung Cancer
,
AACR
Read More ›
Personalizing Immunotherapy in NSCLC Using PD-L1 and Tumor Mutation Burden as Biomarkers
By
Wayne Kuznar
Lung Cancer
,
Web Exclusives
Read More ›
FDA Approves Tecentriq plus Chemotherapy for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer
Lung Cancer
,
FDA Approvals, News & Updates
Read More ›
PACIFIC: Practice-Changing Study in Stage III Unresectable Non–Small-Cell Lung Cancer
By
Phoebe Starr
Web Exclusives
,
Lung Cancer
Read More ›
The Road MAP to Targeted Therapy in Squamous-Cell Carcinoma: Lung Cancer Master Protocol (SWOG S1400) Overview
By
Yasir Y. Elamin, MD
;
Vassiliki A. Papadimitrakopoulou, MD
Lung Cancer
Read More ›
Case: Molecular Pathways in Non–Small Cell Lung Cancer
Lung Cancer
Read More ›
Care Pathway for NSCLC Cuts Chemotherapy Charges
Lung Cancer
Read More ›
Expanding Options for EGFR-Mutant Non–Small Cell Lung Cancer with Afatinib
By
Elizabeth Tsui
;
Karen L. Reckamp, MD, MS
Lung Cancer
Read More ›
FDA Approves Opdivo (Nivolumab) for the Treatment of Patients with Previously Treated Metastatic Squamous Non–Small Cell Lung Cancer
By
Suresh Ramalingam, MD
Lung Cancer
Read More ›
Page 1 of 2
1
2